After soft Nike earnings, we have a big decision to make on the stock

Nike reported FY2026 Q4 revenue of $10.97B (down 1% YoY) topping the $10.86B Street estimate, and EPS rose 42% to $0.20 vs $0.13 consensus. However, shares fell ~2% after-hours and the outlook reiterated “flattish” EPS YoY through the first two quarters of FY2027, with management pointing to tighter buys and improving gross margins sooner. The quarter also references a $52c EPS benefit from the expected recovery of IEEPA tariffs, while North America sales missed expectations for a second straight quarter and China revenue declined 12% YoY.

Analysis

The important read-through is that this is not a clean demand recovery; it is a margin-management story with a low-quality EPS beat. A non-recurring tariff benefit makes headline earnings look better than the underlying run-rate, so the market should care more about whether Nike can hold full-price selling than whether it can report a quarterly beat. That means the stock can stabilize, but a durable rerating likely needs organic revenue inflection, not just inventory discipline.

Second-order, Nike’s tighter promotions should help its own gross margin, but it shifts pain downstream to retailers and wholesalers that depended on Nike traffic and discounting. Over the next 1-3 months, that is a relative-positive for better-positioned premium brands taking share in performance running and for retailers with cleaner inventory, while extending the pressure on legacy athletic apparel exposure. The bigger competitive risk is that every quarter of delay gives rivals more time to lock in shelf space and consumer habit, especially in categories where product innovation matters more than brand awareness.

Catalysts are the next couple of sell-through checks and the November Investor Day/new CFO reset. If management only reiterates flattish earnings while revenue stays under pressure, the multiple is vulnerable to further compression; if it can show sequential stabilization without promotion intensity, shorts will be forced to cover. The contrarian view is that the market may be over-focusing on the slow turnaround and underestimating margin leverage once markdowns fade, but I think it is still underestimating how competitive the category has become and how little room there is for another guide cut.

Key Decisions for Investors

• Keep NKE underweight and fade rallies into the low-$40s; target the mid-$30s over 1-3 months if back-to-school sell-through does not improve. Thesis breaks if management raises FY27 revenue guidance or shows clear sequential acceleration.
• Pair trade: long ONON or DECK versus short NKE to express market-share transfer in running/premium footwear. Hold into Investor Day; attractive if Nike remains stuck in a low-growth, margin-first posture.
• Do not chase a long in NKE on the headline beat; wait for one more quarter of proof on organic demand and channel health before re-adding. This is a proof-of-execution trade, not a valuation screen.
• Use TGT and broader discretionary retail as a consumer-demand check, not a direct trade: if discretionary comps deteriorate alongside Nike, the issue broadens from company-specific execution to a weaker consumer backdrop.